Noor A. M. Bakker

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings et al. · Nature Medicine · 2019 · 889 citations · Full text

Medicine, Immunology, Oncology +17

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy

Meike E. W. Logtenberg, J.H. Marco Jansen, Matthijs Raaben et al. · Nature Medicine · 2019 · 242 citations · Full text

Life Sciences, Molecular Biology, Oncology +13

IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer

Olga Blomberg, Lorenzo Spagnuolo, Hannah Garner et al. · Cancer Cell · 2022 · 207 citations · Full text

Life Sciences, Immunology, Oncology +16

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up

Joost H. van den Berg, Bianca Heemskerk, Nienke van Rooij et al. · Journal for ImmunoTherapy of Cancer · 2020 · 197 citations · Full text

Life Sciences, Immunology, Oncology +17

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

Iris Nederlof, Olga I. Isaeva, Manon de Graaf et al. · Nature Medicine · 2024 · 67 citations · Full text

Life Sciences, Immunology, Oncology +17